SmartChest | Chest X-ray triage | USA

FDA | Cardiothoracic & Emergency | X-ray | Amplifier Partner

Description of use

SmartChest analyzes frontal chest radiographs of adults, PA or AP, for suspected pneumothorax and pleural effusion. When it finds one, it sends a passive notification to the PACS. The suspected finding is named in the DICOM tags and a summary image flags the study, so IDS7 can move the exam up the worklist. The notification serves prioritization only, and the radiologist still reads every exam. In the two FDA standalone studies, each on 300 US chest radiographs, SmartChest reached an AUC of 0.989 for pneumothorax and 0.975 for pleural effusion. SmartChest, developed by Milvue, is FDA 510(k) cleared (K232410) as a Class II device (21 CFR 892.2080). It is intended to aid clinicians and does not replace their judgment. Rx only. See the IFU for indications and warnings.

The application content is provided by the respective AI vendors.